Viglya wishes to establish transparent and open communication with its stakeholders. This section offers new and updated information regarding the company and the life science sector.


AEMPS: Solicitudes de autorización de comercialización de medicamentos de uso humano. Monográfico de bases legales

Sorry, this entry is only available in Español.


Comments are closed.

ANSM: Essai clinique Rennes: l’ANSM poursuit ses investigations
FDA: Califf, FDA top officials call for sweeping review of agency opioids policies
AEMPS: Expertos internacionales explican sus avances en terapia génica para tratar enfermedades hematológicas
UK MHRA Official Statistics: Medicines: licensing time-based performance measures
FDA: MedWatch Tips and Tools (January 2016)
AEMPS: Documentación para la realización de ensayos clínicos con medicamentos en España
AEMPS: Documento de preguntas y respuestas frecuentes relativas al Electronic Application Form (e-AF), de aplicación para medicamentos de uso humano y medicamentos veterinarios
FDA Draft Guidance for Industry: Human Factors Studies and Related Clinical Study Considerations in Combination Product Design and Development
FDA Guidance for Industry: Applying Human Factors and Usability Engineering to Medical Devices
EMA: How to facilitate development of cancer immunotherapies